Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

In Vitro Diagnostics Companies

Several companies are actively involved in the development, production, and commercialization of in vitro diagnostic (IVD) products and solutions, which are essential for the detection and monitoring of various diseases and medical conditions. These companies contribute significantly to the advancement of healthcare by providing reliable and accurate diagnostic tools for clinical laboratories, healthcare facilities, and research institutions.

*Disclaimer: List of key companies in no particular orderLatest in vitro diagnostic (IVD) Companies Update

Sep 2023: With a focus on cancer treatment, women's health, and breathing disorders, Abbott Laboratories and mAbxience Holdings S.L., a Spanish global biotech business, have a deal to launch several biosimilars in emerging markets. The first compounds should go on sale in 2025, while others depend on how quickly clinical development and licensing can be completed. Abbott will register and sell the biosimilars in important developing nations in Southeast Asia, the Middle East, Latin America, and Africa. MAbxience will produce the biosimilars at its GMP-approved facilities in Argentina and Spain. Additionally, mAbxience will oversee seeing some of the still-in-development compounds through their clinical milestones. The partnership strengthens an existing arrangement with mAbxience, started in Latin America in 2018, and broadens Abbott's medication selection in emerging nations.

Oct 2023: Six new recombinant monoclonal anti-idiotypic antibodies specific to dupilumab (Dupixent) and new ipilimumab (Yervoy), evolocumab (Repatha), and secukinumab (Cosentyx) antibodies have been added to Bio-Rad Laboratories, Inc.'s portfolio of recombinant monoclonal anti-idiotypic antibodies. These pre-made antibodies can be consumed to create accurate anti-drug antibody (ADA) and pharmacokinetic (PK) assays for the drugs ipilimumab, dupilumab, evolocumab, and secukinumab, as well as their biosimilars. To become the first supplier of antibodies specific to the drug-target complex, Bio-Rad has also increased the scope of its anti-ipilimumab and anti-secukinumab product lines. This enables the detection of bound drugs.

List of in vitro diagnostic (IVD) Key companies in the market

Abbott Laboratories,

Bio-Rad Laboratories Inc.,

Hoffman-LA Roche AG,

Grifols S.A.,

bioMerieux S.A.,

DiaSorin S.p.A.,

Ortho Clinical Diagnostics,

Qiagen N.V.,

Siemens AG,

Becton Dickinson & Company

In Vitro Diagnostics Market Highlights:

In Vitro Diagnostics Market Size

In Vitro Diagnostics Market Trends

In Vitro Diagnostics Market Analysis

In Vitro Diagnostics Market Share

In Vitro Diagnostics Market Highlights:

In Vitro Diagnostics Market Trends

In Vitro Diagnostics Market Analysis

In Vitro Diagnostics Market Share

In Vitro Diagnostics Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.